Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics

NCT05669287 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05669287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05669287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 22, 2017
Completion date
June 1, 2023
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pdac - pancreatic ductal adenocarcinoma